ICON

Jonathan M Fishbein, M.D. has been appointed vice president and Global Head for the Infectious Disease & Vaccines Therapeutic Group at ICON Clinical Research. He will oversee the growth and management of the infectious disease portfolio.

Dr. Fishbein has extensive experience in the planning and execution of clinical research in a broad range of therapeutic areas. He joined the company in 2009 from the National Institute of Allergy and Infectious Diseases (NIAID) in Bethesda, MD, where he served as director of the Office for Policy in Clinical Research Operations at the NIAID’s Division of AIDS, as well as special assistant to the Deputy Director of the NIAID and senior fellow at the International Center for Research on Women. Prior to this, Dr. Fishbein held various positions at PAREXEL, including vice president of North American Medical Services.

Dr. John Hubbard, group president for Global Clinical Research Services said: “We’re delighted to welcome Dr. Fishbein to ICON Clinical Research where he will oversee the strategic development of our burgeoning infectious disease therapeutic area, which complements our well established and growing vaccine business. His wealth of clinical research experience across a broad range of therapeutic areas is a valuable asset to the team.”